RSAD CRISPR Plasmide
Santa Cruz Biotechnology, Inc. bietet eine Vielzahl von Produkten zur Editierung von Genen an einschließlich CRISPR/Cas9 Knockout und CRISPR Double Nickase Plasmide für das Gen Silencing. RSAD Gen Silencer sind erhältlich als RSAD CRISPR/Cas9 Knockout Plasmide und RSAD Double Nickase Plasmide. RSAD CRISPR/dCas9 Aktivierungsplasmide und CRISPR Lenti Aktivierungssysteme für die Aktivierung von Genen sind ebenfalls erhältlich. Gen Silencer und Aktivatoren sind äußerst hilfreich bei der Untersuchung von Genen in Kombination mit den Antikörpern zur Detektion entsprechender Proteine.
RSAD CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
RSAD1 CRISPR/Cas9 KO Plasmid (h) | sc-412515 | h | Gene Knockout | GFP | 0 | ||
RSAD1 HDR Plasmid (h) | sc-412515-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
RSAD1 Double Nickase Plasmid (h) | sc-412515-NIC | h | Gene Knockout | Puromycin | 0 | ||
RSAD1 Double Nickase Plasmid (h2) | sc-412515-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
RSAD1 CRISPR/Cas9 KO Plasmid (m) | sc-433593 | m | Gene Knockout | GFP | 0 | ||
RSAD1 HDR Plasmid (m) | sc-433593-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
RSAD1 Double Nickase Plasmid (m) | sc-433593-NIC | m | Gene Knockout | Puromycin | 0 | ||
RSAD1 Double Nickase Plasmid (m2) | sc-433593-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
RSAD2 CRISPR/Cas9 KO Plasmid (h) | sc-402884 | h | Gene Knockout | GFP | 0 | ||
RSAD2 HDR Plasmid (h) | sc-402884-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
RSAD2 Double Nickase Plasmid (h) | sc-402884-NIC | h | Gene Knockout | Puromycin | 0 | ||
RSAD2 Double Nickase Plasmid (h2) | sc-402884-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
RSAD2 CRISPR/Cas9 KO Plasmid (m) | sc-425475 | m | Gene Knockout | GFP | 0 | ||
RSAD2 HDR Plasmid (m) | sc-425475-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
RSAD2 Double Nickase Plasmid (m) | sc-425475-NIC | m | Gene Knockout | Puromycin | 0 | ||
RSAD2 Double Nickase Plasmid (m2) | sc-425475-NIC-2 | m | Gene Knockout | Puromycin | 0 |
RSAD CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
RSAD1 CRISPR Activation Plasmid (h) | sc-412515-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RSAD1 CRISPR Activation Plasmid (h2) | sc-412515-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RSAD1 Lentiviral Activation Particles (h) | sc-412515-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RSAD1 Lentiviral Activation Particles (h2) | sc-412515-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RSAD1 CRISPR Activation Plasmid (m) | sc-433593-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RSAD1 CRISPR Activation Plasmid (m2) | sc-433593-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RSAD1 Lentiviral Activation Particles (m) | sc-433593-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RSAD1 Lentiviral Activation Particles (m2) | sc-433593-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RSAD2 CRISPR Activation Plasmid (h) | sc-402884-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RSAD2 CRISPR Activation Plasmid (h2) | sc-402884-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RSAD2 Lentiviral Activation Particles (h) | sc-402884-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RSAD2 Lentiviral Activation Particles (h2) | sc-402884-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RSAD2 CRISPR Activation Plasmid (m) | sc-425475-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RSAD2 CRISPR Activation Plasmid (m2) | sc-425475-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RSAD2 Lentiviral Activation Particles (m) | sc-425475-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RSAD2 Lentiviral Activation Particles (m2) | sc-425475-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |